[1]徐雪峰.无创双水平气道正压通气在急性呼吸窘迫综合征患者中的应用效果分析[J].医学信息,2019,32(03):118-120.[doi:10.3969/j.issn.1006-1959.2019.03.037]
　XU Xue-feng.Analysis of Application Effect of Non-invasive Bi-level Positive Airway Pressure Ventilation in Patients with Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2019,32(03):118-120.[doi:10.3969/j.issn.1006-1959.2019.03.037]
点击复制

无创双水平气道正压通气在急性呼吸窘迫综合征患者中的应用效果分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年03期
页码:
118-120
栏目:
临床研究
出版日期:
2019-02-01

文章信息/Info

Title:
Analysis of Application Effect of Non-invasive Bi-level Positive Airway Pressure Ventilation in Patients with Acute Respiratory Distress Syndrome
文章编号:
1006-1959（2019）03-0118-03
作者:
徐雪峰
（广元市昭化区人民医院急诊外科，四川 广元 628021）
Author(s):
XU Xue-feng
(Emergency Surgery,People's Hospital of Zhaohua District,Guangyuan 628021,Sichuan,China)
关键词:
急性呼吸窘迫综合征; 双水平气道正压通气; 气血分压
Keywords:
Acute respiratory distress syndrome; Bi-level positive airway pressure; Blood partial pressure
分类号:
R563.8
DOI:
10.3969/j.issn.1006-1959.2019.03.037
文献标志码:
A
摘要:
目的 对急性呼吸窘迫综合征（ARDS）患者采取无创双水平气道正压通气治疗的应用效果进行分析。方法 选取2017年2月~2018年1月我院收治的50例ARDS患者，随机分为对照组和研究组，每组25例。对照组采取鼻塞式持续气道正压通气治疗（NCPAP），研究组采取双水平气道正压通气治疗（BiPAP），对比两组治疗前、治疗48 h的PaO2、PaCO2、SpO2指标、氧疗时间以及治疗成功率。结果 研究组患者经治疗48 h的PaO2、PaCO2、SpO2指标均优于对照组，差异具有统计学意义（P＜0.05）；研究组氧疗时间少于对照组[（70.35±14.33）h vs （88.79±12.63）h]，治疗成功率高于对照组（96.00% vs 80.00%），差异具有统计学意义（P＜0.05）。结论 采取无创双水平气道正压通气治疗ARDS患者，可显著改善患者的气血分压指标，缩短氧疗时间，提高治疗成功率。
Abstract:
Objective To analyze the application effect of non-invasive bi-level positive airway pressure therapy in patients with acute respiratory distress syndrome (ARDS). Methods A total of 50 patients with ARDS admitted to our hospital from February 2017 to January 2018 were randomly divided into control group and study group, with 25 cases in each group. The control group was treated with nasal continuous positive airway pressure (NCPAP), and the study group was treated with bi-level positive airway pressure (BiPAP). The two groups were compared with PaO2, PaCO2, and SpO2 for 48 hours before treatment. Time and treatment success rate. Results The PaO2, PaCO2 and SpO2 indexes of the study group were better than those of the control group at 48 h,the difference was statistically significant (P<0.05). The oxygen treatment time of the study group was lower than that of the control group [(70.35±14.33)h vs (88.79±12.63)h], and the success rate of treatment was higher than that of the control group (96.00% vs 80.00%),the difference was statistically significant (P<0.05). Conclusion Non-invasive bi-level positive airway pressure therapy for patients with ARDS can significantly improve the blood pressure index, shorten the oxygen therapy time and improve the treatment success rate.

参考文献/References:


[1]吴乃许.经鼻双水平气道正压通气联合肺表面活性物质在早产儿呼吸窘迫综合征治疗中的应用研究[J].中国医学工程,2015,23(6):3-4.
[2]代玉静,苏艳霞,佟丽.双水平气道正压通气序贯治疗早产儿呼吸窘迫综合征的疗效[J].中国新生儿科杂志,2015,30(1):56-58.
[3]杜梅芝.双水平气道正压通气治疗新生儿呼吸窘迫综合征的临床疗效分析[J].医学理论与实践,2018,31(4):560-562.
[4]林报忠,郑通喜.肺表面活性物质联合双水平气道正压通气治疗新生儿呼吸窘迫综合征的临床疗效[J].实用心脑肺血管病杂志,2017,25(7):77-80.
[5]杨璐颖.肺表面活性物质联合双水平气道正压通气治疗早产儿呼吸窘迫综合征的效果[J].中国妇幼保健,2018,33(7):1548-1550.
[6]Coudroy R,Frat JP,Boissier F,et al.Early Identification of Acute Respiratory Distress Disorder in the Absence of Positive Pressure Ventilation: Implications for Revision of the Berlin Criteria for Acute Respiratory Distress Syndrome[J].Critical Care Medicine,2018,46(4):540-546.
[7]车伟坤,凌卫滨,葛书霞,等.双水平气道正压通气治疗早产儿呼吸窘迫综合征的疗效观察[J].河北医药,2016,38(8):1179-1181.

相似文献/References:

[1]何广宾,左海涛,陈永青.呼吸机相关性肺炎对急性呼吸窘迫综合征患者预后的影响[J].医学信息,2022,35(11):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
　HE Guang-bin,ZUO Hai-tao,CHEN Yong-qing.Effect of Ventilator Associated Pneumonia on Prognosis of Patients with Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2022,35(03):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
[2]孙继飞,张 岚.肺表面活性物质治疗足月新生儿急性呼吸窘迫综合征疗效观察[J].医学信息,2019,32(02):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
　SUN Ji-fei,ZHANG Lan.Therapeutic Effect of Pulmonary Surfactant on Acute Respiratory Distress Syndrome in Full-term Neonates[J].Journal of Medical Information,2019,32(03):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
[3]郑 新,张 颖.血清TNF-α、IL-6、IL-8水平对ARDS患者病情的预测价值[J].医学信息,2020,33(04):177.[doi:10.3969/j.issn.1006-1959.2020.04.060]
　ZHENG Xin,ZHANG Ying.Predictive Value of Serum TNF-α,IL-6 and IL-8 Levels in Patients with ARDS[J].Journal of Medical Information,2020,33(03):177.[doi:10.3969/j.issn.1006-1959.2020.04.060]
[4]张 曌,黄 斌.脓毒症并发ARDS的发病机制及预后评估研究进展[J].医学信息,2022,35(23):176.[doi:10.3969/j.issn.1006-1959.2022.23.039]
　ZHANG Zhao,HUANG Bin.Research Progress on Pathogenesis and Prognosis Evaluation of Sepsis Complicated with ARDS[J].Journal of Medical Information,2022,35(03):176.[doi:10.3969/j.issn.1006-1959.2022.23.039]
[5]王 凯,田国栋.连续血液净化联合血必净对ARDS患者氧化应激、APACHEⅡ评分的影响[J].医学信息,2021,34(22):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
　WANG Kai,TIAN Guo-dong.Effect of Continuous Blood Purification Combined with Xuebijing on Oxidative Stress and APACHEⅡ Score in ARDS Patients[J].Journal of Medical Information,2021,34(03):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
[6]吕 冰,田利成,何振芬.呼气末二氧化碳分压监测在急性呼吸窘迫综合征机械通气中的应用[J].医学信息,2022,35(03):115.[doi:10.3969/j.issn.1006-1959.2022.03.028]
　LYU Bing,TIAN Li-cheng,HE Zhen-fen.Application of End-tidal Carbon Dioxide Partial Pressure Monitoring inMechanical Ventilation of Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2022,35(03):115.[doi:10.3969/j.issn.1006-1959.2022.03.028]
[7]康凤尔,姚 杨,曹晓梅,等.ECMO治疗急性呼吸窘迫综合征预后危险因素的Meta分析[J].医学信息,2023,36(23):22.[doi:10.3969/j.issn.1006-1959.2023.23.006]
　KANG Feng-er,YAO Yang,CAO Xiao-mei,et al.Meta-analysis of Prognostic Risk Factors of ECMO in the Treatment of Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2023,36(03):22.[doi:10.3969/j.issn.1006-1959.2023.23.006]

更新日期/Last Update: 2019-02-25